Law360, New York (September 07, 2012, 7:47 PM ET) -- The Second Circuit on Friday affirmed a win for Eli Lilly & Co. in multidistrict litigation over the antipsychotic drug Zyprexa, ruling Lilly isn't liable for failing to warn a man of diabetes risks associated with the drug because he didn't show his doctors' prescription decisions hinged on the drugmaker's warnings.
Plaintiff Arthur McElroy challenged a summary judgment ruling in favor of Lilly in a suit accusing the drugmaker of failing to warn him of the risks associated with taking Zyprexa for his schizophrenia. McElroy said...
2nd Circ. Lets Lilly Off Hook In Zyprexa Diabetes Suit
To view the full article, take a free trial now.
